HIV-1 gp120-induced Endothelial Cell Dysfunction
HIV-1 gp120-induced Endothelial Cell Dysfunction
批准号:
7213429
负责人:
GEORGETTE D. KANMOGNE
金额:
$10.64万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-04-01 至 2008-03-31
关键词:
AIDS Dementia ComplexAffectAntibodiesApoptosisApoptoticBCL2 geneBlood - brain barrier anatomyBrainBrain InjuriesCCR5 geneCD95 AntigensCXCR4 geneCalciumCaspaseCessation of lifeChemokine (C-C Motif) Receptor 5ComplexCyclic AMP-Dependent Protein KinasesDataDementiaDextransDisruptionEndothelial CellsEndotheliumExclusionFluoresceinFluoresceinsFluorescent Antibody TechniqueFunctional disorderGenesHIVHIV Envelope Protein gp120HIV encephalitisHIV-1HumanImmunofluorescence ImmunologicInfectionInvadedKnowledgeLabelLaboratoriesLigandsMeasuresMediatingMorbidity - disease rateNeuraxisNeuropathogenesisPathogenesisPathway interactionsPatientsPermeabilityPlayProtein Kinase CProtein Tyrosine KinaseProteinsRoleSignal Transduction PathwayStagingSystemTestingTherapeuticTherapeutic InterventionTight JunctionsTrypan BlueTumor Necrosis Factor Ligand Superfamily Member 6ViralVirus DiseasesWestern Blottingbasecell injurycerebral atrophychemokine receptordesigndextranenv Gene Productsgp-120 Antigenimprovedneurotoxicnoveloccludinpreventresearch study
中文摘要
描述(申请人提供):人类免疫缺陷病毒(HIV)在感染的早期阶段入侵大脑对于感染晚期的患者来说,中枢神经系统(CNS)功能障碍是常见的致病原因,经常导致进行性痴呆、脑萎缩和死亡。有证据表明,HIV和/或HIV相关蛋白在HIV相关性痴呆(HAD)复合体的发病机制中起关键作用。要阐明HAD的发病机制,了解HIV侵袭大脑的机制是重要的。血脑屏障的破坏在HAD患者中很常见,尽管缺乏有效的HIV感染脑血管内皮细胞。HIV-1包膜蛋白gp120存在于HIV脑炎患者的大脑中,是神经毒性的最新证据,来自我们实验室和其他人的证据表明,gp120对脑内皮细胞有直接影响。我们的假设是gp120直接导致血脑屏障功能障碍,并在病毒侵袭脑中发挥重要作用。为了验证这一假说,我们计划实现以下目标。目的:为了验证HIV-1gp120蛋白对人脑微血管内皮细胞的毒性并直接诱导血脑屏障的破坏和/或破坏的假说,我们将检测内皮细胞的通透性和凋亡率。目的2为了验证gp120蛋白暴露于人脑微血管内皮细胞导致紧密连接蛋白丢失的假说,我们将用免疫印迹和免疫荧光方法检测occludin、Claudia-5和zonula occludens-1的表达。目的3:确定趋化因子受体是否参与gp120诱导的血脑屏障的破坏和/或损伤。目的4:确定gp120诱导的血脑屏障功能障碍的信号转导途径。这些实验的数据将有助于确定gp120在破坏血脑屏障完整性和艾滋病毒入侵大脑中所起的作用,并将提出预防艾滋病毒感染期间gp120介导的脑内皮功能障碍的治疗方法。
英文摘要
DESCRIPTION (provided by applicant): The human immunodeficiency virus (HIV) invades the brain in the early stages of infection For patients in the advanced stage of infection, dysfunction of the central nervous system (CNS) is a common cause of morbidity and often leads to progressive dementia, cerebral atrophy and death. Evidence suggest that HIV and /or HIV-associated proteins are critical to the pathogenesis of the HIV-associated dementia (HAD)complex .To elucidate the pathogenesis of HAD, it is important to understand by what mechanisms HIV invades the brain. Breakdown of the blood-brain barrier is commonly seen in patients with HAD, despite the lack of productive HIV-infection of the brain endothelium. The HIV-1 envelope protein gp120 is present in the brain of patients with HIV encephalitis, and is neurotoxic Recent evidence from our laboratory, and by others, suggests a direct effect of gp120 on the brain endothelium. It is our hypothesis that gp120 directly causes blood-brain barrier dysfunction and plays a major role in viral invasion of the brain To test this hypothesis, we plan the following aims. Aim 1: To test the hypothesis that HIV-1 gp120 proteins are toxic to human brain microvascular endothelial cells and directly induce a disruption and/or damage of the blood-brain barrier we will measure endothelial cell permeability and apoptosis. Aim 2 To test the hypothesis that exposure of gp120 proteins to human brain microvascular endothelial cells result in the loss of tight junction proteins we will assess the expression of occludin, claudia-5 and zonula occludens-1 using western blotting and immunofluorescence. Aim 3: To determine if chemokine receptors are involved in gp120-induced blood-brain barrier disruption and/or damage Aim 4: To determine the signal transduction pathways involved in gp120-induced blood-brain barrier dysfunction. Data from these experiments will help determine the role that gp120 plays in the breach of blood-brain barrier integrity and HIV invasion of the brain, and will suggest therapeutic approaches to preventing gp120-mediated dysfunction of the brain endothelium during HIV infection.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.mvr.2008.11.003
发表时间:
2009-03
期刊:
MICROVASCULAR RESEARCH
影响因子:
3.1
作者:
[Yang, Bo, Akhter, Sidra, Chaudhuri, Anathbandhu, Kanmogne, Georgette D.]
通讯作者:
Kanmogne, Georgette D.
PREVENTING ALZHEIMER’S DISEASE-LIKE BRAIN PATHOLOGY IN HIV INFECTION BY TARGETING CCR5
-
批准号:10700624
-
项目类别:
-
资助金额:$69.07万
-
财政年份:2023
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
Preventing Alzheimer's Disease Like Brain Pathology in HIV Infection by Targeting CCR5
-
批准号:10161318
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2020
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
Preventing Alzheimer's Disease Like Brain Pathology in HIV Infection by Targeting CCR5
-
批准号:10301369
-
项目类别:
-
资助金额:$22.98万
-
财政年份:2020
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
HIV Genetic Diversity and Viral Neuropathogenesis
-
批准号:8599489
-
项目类别:
-
资助金额:$67.97万
-
财政年份:2012
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
HIV Genetic Diversity and Viral Neuropathogenesis
-
批准号:8426089
-
项目类别:
-
资助金额:$63.98万
-
财政年份:2012
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
HIV Genetic Diversity and Viral Neuropathogenesis
-
批准号:8779742
-
项目类别:
-
资助金额:$53.79万
-
财政年份:2012
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
HIV Genetic Diversity and Viral Neuropathogenesis
-
批准号:8257050
-
项目类别:
-
资助金额:$69.66万
-
财政年份:2012
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
Blood brain barrier immune compromise in NeuroAIDS
-
批准号:8055998
-
项目类别:
-
资助金额:$29.11万
-
财政年份:2008
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
Blood brain barrier immune compromise in NeuroAIDS
-
批准号:7619271
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2008
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
Blood brain barrier immune compromise in NeuroAIDS
-
批准号:7806523
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2008
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
Blood brain barrier immune compromise in NeuroAIDS
-
批准号:8247819
-
项目类别:
-
资助金额:$29.11万
-
财政年份:2008
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
NeuroAIDS in Cameroon: Molecular determinants
-
批准号:7281370
-
项目类别:
-
资助金额:$17.22万
-
财政年份:2007
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
NeuroAIDS in Cameroon: Molecular determinants
-
批准号:7426434
-
项目类别:
-
资助金额:$19.55万
-
财政年份:2007
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
Macrophage, blood-brain barrier, and modulation of neurodegeneration
-
批准号:8033780
-
项目类别:
-
资助金额:$23.29万
-
财政年份:2003
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
HIV-1 gp120-induced Endothelial Cell Dysfunction
-
批准号:6709405
-
项目类别:
-
资助金额:$4.65万
-
财政年份:2003
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
HIV-1 gp120-induced Endothelial Cell Dysfunction
-
批准号:6858621
-
项目类别:
-
资助金额:$10.34万
-
财政年份:2003
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
Macrophage, blood-brain barrier, and modulation of neurodegeneration
-
批准号:8377758
-
项目类别:
-
资助金额:$22.63万
-
财政年份:2003
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
HIV-1 gp120-induced Endothelial Cell Dysfunction
-
批准号:6656166
-
项目类别:
-
资助金额:$10.05万
-
财政年份:2003
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
HIV-1 gp120-induced Endothelial Cell Dysfunction
-
批准号:7015421
-
项目类别:
-
资助金额:$5.54万
-
财政年份:2003
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
Macrophage, blood-brain barrier, and modulation of neurodegeneration
-
批准号:8230867
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2003
-
负责人:GEORGETTE D. KANMOGNE
-
依托单位:
海外基金